Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering

Mounica Yanamandala; Wuqiang Zhu; Daniel J. Garry; Timothy J. Kamp; Joshua M. Hare; Ho wook Jun; Young sup Yoon; Nenad Bursac; Sumanth D. Prabhu; Gerald W. Dorn; Roberto Bolli; Richard N. Kitsis; Jianyi Zhang

doi:10.1016/j.jacc.2017.06.012

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering

Mounica Yanamandala, Wuqiang Zhu, Daniel J. Garry, Timothy J. Kamp, Joshua M. Hare, Ho wook Jun, Young sup Yoon, Nenad Bursac, Sumanth D. Prabhu, Gerald W. Dorn, Roberto Bolli, Richard N. Kitsis, Jianyi Zhang

BioMedical Science Institute

Research output: Contribution to journal › Review article › peer-review

75 Citations (Scopus)

Abstract

Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.

Original language	English
Pages (from-to)	766-775
Number of pages	10
Journal	Journal of the American College of Cardiology
Volume	70
Issue number	6
DOIs	https://doi.org/10.1016/j.jacc.2017.06.012
Publication status	Published - 2017 Aug 8

Bibliographical note

Funding Information:
The authors gratefully acknowledge the National Institutes of Health (NIH) support of their research, NIH UO1 HL134764, the Progenitor Cell Biology Consortium (grant HL099997), and the Symposium held at University of Alabama-Birmingham in March 2016. This work was a product of discussions at the NIH Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering Symposium, March 2016.

Publisher Copyright:
© 2017 The Authors

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2017.06.012

Cite this

@article{5d98e0f9be0840c8baaf7eac76229556,

title = "Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering",

abstract = "Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.",

author = "Mounica Yanamandala and Wuqiang Zhu and Garry, {Daniel J.} and Kamp, {Timothy J.} and Hare, {Joshua M.} and Jun, {Ho wook} and Yoon, {Young sup} and Nenad Bursac and Prabhu, {Sumanth D.} and Dorn, {Gerald W.} and Roberto Bolli and Kitsis, {Richard N.} and Jianyi Zhang",

note = "Funding Information: The authors gratefully acknowledge the National Institutes of Health (NIH) support of their research, NIH UO1 HL134764, the Progenitor Cell Biology Consortium (grant HL099997), and the Symposium held at University of Alabama-Birmingham in March 2016. This work was a product of discussions at the NIH Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering Symposium, March 2016. Publisher Copyright: {\textcopyright} 2017 The Authors",

year = "2017",

month = aug,

day = "8",

doi = "10.1016/j.jacc.2017.06.012",

language = "English",

volume = "70",

pages = "766--775",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "6",

}

TY - JOUR

T1 - Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering

AU - Yanamandala, Mounica

AU - Zhu, Wuqiang

AU - Garry, Daniel J.

AU - Kamp, Timothy J.

AU - Hare, Joshua M.

AU - Jun, Ho wook

AU - Yoon, Young sup

AU - Bursac, Nenad

AU - Prabhu, Sumanth D.

AU - Dorn, Gerald W.

AU - Bolli, Roberto

AU - Kitsis, Richard N.

AU - Zhang, Jianyi

N1 - Funding Information: The authors gratefully acknowledge the National Institutes of Health (NIH) support of their research, NIH UO1 HL134764, the Progenitor Cell Biology Consortium (grant HL099997), and the Symposium held at University of Alabama-Birmingham in March 2016. This work was a product of discussions at the NIH Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering Symposium, March 2016. Publisher Copyright: © 2017 The Authors

PY - 2017/8/8

Y1 - 2017/8/8

N2 - Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.

AB - Transplantations of various stem cells or their progeny have repeatedly improved cardiac performance in animal models of myocardial injury; however, the benefits observed in clinical trials have been generally less consistent. Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks. Advances in tissue and genetic engineering techniques are expected to improve the survival and integration of transplanted cells, and to support structural, functional, and bioenergetic recovery of the recipient hearts. Specifically, application of a prefabricated cardiac tissue patch to prevent dilation and to improve pumping efficiency of the infarcted heart offers a promising strategy for making stem cell therapy a clinical reality.

UR - http://www.scopus.com/inward/record.url?scp=85028597123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028597123&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2017.06.012

DO - 10.1016/j.jacc.2017.06.012

M3 - Review article

C2 - 28774384

AN - SCOPUS:85028597123

SN - 0735-1097

VL - 70

SP - 766

EP - 775

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 6

ER -

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this